SOM Biotech slutför rekryteringsprocessen i fas IIb-studien av behandling av chorea vid Huntingtons sjukdom

SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical […]